Search research articles
Contact Us
Filters
Showing results (71-80 of 194) with videos related to
Page
of 20
Sort By:
JACC. Cardiovascular Interventions
|
February 21, 2017
Integrated Use of Perfusion SPECT/CTA Fusion Imaging and Pulmonary Balloon Angioplasty for Chronic Pulmonary Thromboembolism
Ryoji Yanagisawa, Kenneth A Fetterly, Geoffrey B Johnson, et al.
European Journal of Applied Physiology
|
April 2, 2009
The effects of sildenafil and acetazolamide on breathing efficiency and ventilatory control during hypoxic exercise
Sophie Lalande, Eric M Snyder, Thomas P Olson, et al.
Chest
|
June 18, 2011
The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension
Raymond L Benza, Mardi Gomberg-Maitland, Dave P Miller, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
April 19, 2014
Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study
Robert P Frantz, Louise Durst, Charles D Burger, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 21, 2005
Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity
Sudhir S Kushwaha, Zain Khalpey, Robert P Frantz, et al.
Chest
|
September 11, 2022
Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)
Luke S Howard, Stephan Rosenkranz, Robert P Frantz, et al.
Pulmonary Circulation
|
January 27, 2015
Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: results of a cross-sectional survey
Eric R Fenstad, Tait D Shanafelt, Jeff A Sloan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 15, 2012
Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey
Keith M Swetz, Tait D Shanafelt, Linda B Drozdowicz, et al.
Pulmonary Circulation
|
September 10, 2013
A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
Richard N Channick, Robert P Frantz, Steven M Kawut, et al.
The European Respiratory Journal
|
November 6, 2025
Inhaled treprostinil improves cardiac output during exertion in interstitial lung disease
Yogesh N V Reddy, Robert P Frantz, Alexander C Egbe, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 194) with videos related to
Sort By:
Page
of 20
JACC. Cardiovascular Interventions
|
February 21, 2017
Integrated Use of Perfusion SPECT/CTA Fusion Imaging and Pulmonary Balloon Angioplasty for Chronic Pulmonary Thromboembolism
Ryoji Yanagisawa, Kenneth A Fetterly, Geoffrey B Johnson, et al.
European Journal of Applied Physiology
|
April 2, 2009
The effects of sildenafil and acetazolamide on breathing efficiency and ventilatory control during hypoxic exercise
Sophie Lalande, Eric M Snyder, Thomas P Olson, et al.
Chest
|
June 18, 2011
The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension
Raymond L Benza, Mardi Gomberg-Maitland, Dave P Miller, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
April 19, 2014
Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study
Robert P Frantz, Louise Durst, Charles D Burger, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 21, 2005
Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity
Sudhir S Kushwaha, Zain Khalpey, Robert P Frantz, et al.
Chest
|
September 11, 2022
Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)
Luke S Howard, Stephan Rosenkranz, Robert P Frantz, et al.
Pulmonary Circulation
|
January 27, 2015
Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: results of a cross-sectional survey
Eric R Fenstad, Tait D Shanafelt, Jeff A Sloan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 15, 2012
Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey
Keith M Swetz, Tait D Shanafelt, Linda B Drozdowicz, et al.
Pulmonary Circulation
|
September 10, 2013
A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
Richard N Channick, Robert P Frantz, Steven M Kawut, et al.
The European Respiratory Journal
|
November 6, 2025
Inhaled treprostinil improves cardiac output during exertion in interstitial lung disease
Yogesh N V Reddy, Robert P Frantz, Alexander C Egbe, et al.
Page
of 20